Your browser does not support JavaScript! MOTION SICKNESS RELIEF (MECLIZINE HCL) TABLET, CHEWABLE [SUPERVALU INC.]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

MOTION SICKNESS RELIEF (meclizine hcl) tablet, chewable
[SUPERVALU INC.]


Category DEA Schedule Marketing Status
HUMAN OTC DRUG LABEL OTC monograph final
NOTE:MOST OTC DRUGS ARE NOT REVIEWED AND APPROVED BY FDA, HOWEVER THEY MAY BE MARKETED IF THEY COMPLY WITH APPLICABLE REGULATIONS AND POLICIES. FDA HAS NOT EVALUATED WHETHER THIS PRODUCT COMPLIES.
Drug Label Sections

Active ingredient (in each tablet)

Meclizine HCl 25 mg

Purpose

Antiemetic

Use

  • prevents and treats nausea, vomiting, or dizzines associated with motion sickness 

Warnings

Do not use

 for children under 12 years of age unless directed by a doctor

Ask a doctor before use if you have

  • glaucoma
  • difficulty in urination due to enlargement of the prostate gland
  • a breathing problem such as emphysema or chronic bronchitis 

Ask a doctor or pharmacist before use if you are

 taking sedatives or tranquilizers

When using this product

  • do not exceed recommended dosage
  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careul when driving a motor vehicle or operating machinery 

If pregnant or breast-feeding,

 ask a health professional before use.

Keep out of reach of children.

 In case of overdose, get medical help or contact a Poison Control Center rigth away.

Directions

  • dosage should be taken one hour before travel starts
  • adults and children 12 years of age and over: take 1 to 2 tablets once daily or as directed by a doctor 

Other information

  • store at controlled room temperature 15º-30ºC (59º-86ºF)
  • protect from heat and humidity
  • for better identification keep talbets in carton until used
  • see end flap for expiration date and lot number 

Inactive ingredients

corn starch, FD&C red #40 aluminum lake, lactose, magnesium stearate, rasberry flavor, silica gel, sodium saccharin

Questions or comments?

 1-877-932-7948

Principal Display Panel

equaline®

compare to Bonine® tablets active ingredients*

NDC 41163-404-21

motion
sickness relief
meclizine HCl 25 mg • antiemetic


• prevents motion sickness
• causes less drowsiness

16 chewable tablets

*This product is not manufactured or distributed by Insight Pharmaceuticals, owner of the registered trademark Bonine® Chewable Tablets.
50844    REV0410D40421

DISTRIBUTED BY SUPERVALU INC.
EDEN PRARIE, MN 55344 USA

TAMPER EVIDENT: DO NOT USE IF CARTON IS OPENED OR BLISTER UNIT IS TORN, BROKEN OR SHOWS ANY SIGNS OF TAMPERING

Equaline 44-404

Equaline 44-404

MOTION SICKNESS RELIEF 
meclizine hcl tablet, chewable
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:41163-404
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
FD&C RED NO. 40 
LACTOSE 
MAGNESIUM STEARATE 
Product Characteristics
ColorPINKScoreno score
ShapeROUNDSize10mm
FlavorRASPBERRYImprint Code 44;404
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:41163-404-211 in 1 CARTON
116 in 1 BLISTER PACK
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart33605/29/2002
Labeler - SUPERVALU INC. (006961411)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.038154464PACK(41163-404)
Establishment
NameAddressID/FEIBusiness Operations
LNK International, Inc.832867894MANUFACTURE(41163-404)

Revised: 11/2012
 
SUPERVALU INC.

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services